SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria
Since December 2019 the world has been dealing with a severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic. The first SARS-CoV-2 vaccine was made available in Europe at the end of 2020. 202 volunteers from the vicinity of the University of Applied Sciences Wiener Neustadt took...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Clinical Immunology Communications |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772613422000178 |
| _version_ | 1811180792282349568 |
|---|---|
| author | Elisabeth Mara Tobias Mader Johannes Gratzer Stefanie Hochegger Thomas Pekar |
| author_facet | Elisabeth Mara Tobias Mader Johannes Gratzer Stefanie Hochegger Thomas Pekar |
| author_sort | Elisabeth Mara |
| collection | DOAJ |
| description | Since December 2019 the world has been dealing with a severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic. The first SARS-CoV-2 vaccine was made available in Europe at the end of 2020. 202 volunteers from the vicinity of the University of Applied Sciences Wiener Neustadt took part in this study; their IgG levels recognizing the RBD of SARS-CoV-2 were determined. The aim was to evaluate the SARS-CoV-2 titer levels of vaccinated, recovered and vaccinated plus recovered persons. We could show that there is a significant difference in the antibody levels of vaccinated, vaccinated plus recovered and only recovered probands. Additionally, the highest antibody levels were found in triple vaccinated persons. Furthermore, the Moderna vaccine seems to have a higher immune response. |
| first_indexed | 2024-04-11T09:09:22Z |
| format | Article |
| id | doaj.art-63ab339e91fe42f1b5bdfd04252d55d1 |
| institution | Directory Open Access Journal |
| issn | 2772-6134 |
| language | English |
| last_indexed | 2024-04-11T09:09:22Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Clinical Immunology Communications |
| spelling | doaj.art-63ab339e91fe42f1b5bdfd04252d55d12022-12-22T04:32:32ZengElsevierClinical Immunology Communications2772-61342022-12-012136141SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in AustriaElisabeth Mara0Tobias Mader1Johannes Gratzer2Stefanie Hochegger3Thomas Pekar4Corresponding author.; Biomedical Science, University of Applied Sciences Wiener Neustadt, AustriaBiomedical Science, University of Applied Sciences Wiener Neustadt, AustriaBiomedical Science, University of Applied Sciences Wiener Neustadt, AustriaBiomedical Science, University of Applied Sciences Wiener Neustadt, AustriaBiomedical Science, University of Applied Sciences Wiener Neustadt, AustriaSince December 2019 the world has been dealing with a severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic. The first SARS-CoV-2 vaccine was made available in Europe at the end of 2020. 202 volunteers from the vicinity of the University of Applied Sciences Wiener Neustadt took part in this study; their IgG levels recognizing the RBD of SARS-CoV-2 were determined. The aim was to evaluate the SARS-CoV-2 titer levels of vaccinated, recovered and vaccinated plus recovered persons. We could show that there is a significant difference in the antibody levels of vaccinated, vaccinated plus recovered and only recovered probands. Additionally, the highest antibody levels were found in triple vaccinated persons. Furthermore, the Moderna vaccine seems to have a higher immune response.http://www.sciencedirect.com/science/article/pii/S2772613422000178SARS-CoV-2RBDIgG determinationVaccine |
| spellingShingle | Elisabeth Mara Tobias Mader Johannes Gratzer Stefanie Hochegger Thomas Pekar SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria Clinical Immunology Communications SARS-CoV-2 RBD IgG determination Vaccine |
| title | SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria |
| title_full | SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria |
| title_fullStr | SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria |
| title_full_unstemmed | SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria |
| title_short | SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria |
| title_sort | sars cov 2 antibody determination in a vaccinated and recovered cohort in austria |
| topic | SARS-CoV-2 RBD IgG determination Vaccine |
| url | http://www.sciencedirect.com/science/article/pii/S2772613422000178 |
| work_keys_str_mv | AT elisabethmara sarscov2antibodydeterminationinavaccinatedandrecoveredcohortinaustria AT tobiasmader sarscov2antibodydeterminationinavaccinatedandrecoveredcohortinaustria AT johannesgratzer sarscov2antibodydeterminationinavaccinatedandrecoveredcohortinaustria AT stefaniehochegger sarscov2antibodydeterminationinavaccinatedandrecoveredcohortinaustria AT thomaspekar sarscov2antibodydeterminationinavaccinatedandrecoveredcohortinaustria |